| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Molecular Immunology, Institute of Development, Aging and Cancer, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, Japan
Department of Cell Biology, Cancer Institute, Toshima-ku, Tokyo, Japan;
Department of Viral Oncology, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto, Japan;
§
Laboratory Animal Research Center, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo, Japan;
¶
Department of Immunology, Tokai University School of Medicine, Isehara, Japan; and
||
Institute for Genome Research and PRESTO Research Project, University of Tokushima, Tokushima, Japan
In the thymic cortex, T lymphocytes are positively selected to survive and committed either to the CD4 single-positive (SP) or the CD8 SP lineage. The SP cells then pass through a step of maturation in the medulla and are delivered to peripheral lymphoid tissues. We examined the role of AML1, the gene encoding a transcription factor, in the above processes by using the transgenic mice expressing a dominant interfering form of AML1 as well as mice targeted heterozygously for AML1. One phenotypic change seen in the AML1-diminished mice was the reduction in the numbers of both CD4 SP and CD8 SP thymocytes, reflecting the partial impairment of the transition from the double-positive to SP stage. In addition, distinct from the above abnormality, perturbed were several aspects of SP cells, including the maturation of SP thymocytes, the recent thymic emigration, and the proliferative responsiveness of peripheral T cells to TCR stimulation. Interestingly, the AML1 diminution caused inhibitory and enhancing effects on the CD4 SP and CD8 SP cells, respectively. These differential effects are most likely related to the reduction in the peripheral CD4 SP/CD8 SP ratio observed in the AML1-diminished mice. The AML1 transcription factor thus maintains the homeostasis of each SP subset by functioning at the later stages of T lymphocyte differentiation.
This article has been cited by other articles:
|
|
 |
|
  S.-i. Ohno, T. Sato, K. Kohu, K. Takeda, K. Okumura, M. Satake, and S. Habu Runx proteins are involved in regulation of CD122, Ly49 family and IFN-{gamma} expression during NK cell differentiation Int. Immunol., January 1, 2008; 20(1): 71 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cammenga, B. Niebuhr, S. Horn, U. Bergholz, G. Putz, F. Buchholz, J. Lohler, and C. Stocking RUNX1 DNA-Binding Mutants, Associated with Minimally Differentiated Acute Myelogenous Leukemia, Disrupt Myeloid Differentiation Cancer Res., January 15, 2007; 67(2): 537 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Abe, K. Kohu, H. Ohmori, K. Hayashi, T. Watanabe, K. Hozumi, T. Sato, S. Habu, and M. Satake Reduction of Runx1 Transcription Factor Activity Up-Regulates Fas and Bim Expression and Enhances the Apoptotic Sensitivity of Double Positive Thymocytes J. Immunol., October 1, 2005; 175(7): 4475 - 4482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kohu, T. Sato, S.-i. Ohno, K. Hayashi, R. Uchino, N. Abe, M. Nakazato, N. Yoshida, T. Kikuchi, Y. Iwakura, et al. Overexpression of the Runx3 Transcription Factor Increases the Proportion of Mature Thymocytes of the CD8 Single-Positive Lineage J. Immunol., March 1, 2005; 174(5): 2627 - 2636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Sun and J. R. Downing Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors Blood, December 1, 2004; 104(12): 3565 - 3572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Anderson, R. Pant, A. L. Miracle, X. Sun, C. A. Luer, C. J. Walsh, J. C. Telfer, G. W. Litman, and E. V. Rothenberg Evolutionary Origins of Lymphocytes: Ensembles of T Cell and B Cell Transcriptional Regulators in a Cartilaginous Fish J. Immunol., May 15, 2004; 172(10): 5851 - 5860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Aliahmad, E. O'Flaherty, P. Han, O. D. Goularte, B. Wilkinson, M. Satake, J. D. Molkentin, and J. Kaye TOX Provides a Link Between Calcineurin Activation and CD8 Lineage Commitment J. Exp. Med., April 19, 2004; 199(8): 1089 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Lorsbach, J. Moore, S. O. Ang, W. Sun, N. Lenny, and J. R. Downing Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression Blood, April 1, 2004; 103(7): 2522 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. North, T. Stacy, C. J. Matheny, N. A. Speck, and M. F.T.R. de Bruijn Runx1 Is Expressed in Adult Mouse Hematopoietic Stem Cells and Differentiating Myeloid and Lymphoid Cells, But Not in Maturing Erythroid Cells Stem Cells, March 1, 2004; 22(2): 158 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishimura, Y. Fukushima-Nakase, Y. Fujita, M. Nakao, S. Toda, N. Kitamura, T. Abe, and T. Okuda VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development Blood, January 15, 2004; 103(2): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ehlers, K. Laule-Kilian, M. Petter, C. J. Aldrian, B. Grueter, A. Wurch, N. Yoshida, T. Watanabe, M. Satake, and V. Steimle Morpholino Antisense Oligonucleotide-Mediated Gene Knockdown During Thymocyte Development Reveals Role for Runx3 Transcription Factor in CD4 Silencing During Development of CD4-/CD8+ Thymocytes J. Immunol., October 1, 2003; 171(7): 3594 - 3604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Komine, K. Hayashi, W. Natsume, T. Watanabe, Y. Seki, N. Seki, R. Yagi, W. Sukzuki, H. Tamauchi, K. Hozumi, et al. The Runx1 Transcription Factor Inhibits the Differentiation of Naive CD4+ T Cells into the Th2 Lineage by Repressing GATA3 Expression J. Exp. Med., July 7, 2003; 198(1): 51 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schwieger, J. Lohler, J. Friel, M. Scheller, I. Horak, and C. Stocking AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency J. Exp. Med., November 4, 2002; 196(9): 1227 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Vaillant, K. Blyth, L. Andrew, J. C. Neil, and E. R. Cameron Enforced Expression of Runx2 Perturbs T Cell Development at a Stage Coincident with {beta}-Selection J. Immunol., September 15, 2002; 169(6): 2866 - 2874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hayashi, N. Abe, T. Watanabe, M. Obinata, M. Ito, T. Sato, S. Habu, and M. Satake Overexpression of AML1 Transcription Factor Drives Thymocytes into the CD8 Single-Positive Lineage J. Immunol., November 1, 2001; 167(9): 4957 - 4965. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
